#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA861988	F	Antiproliferative activity against mouse CT26 cell line	Mus musculus	6		cell-based format	Scientific Literature
2.	ALA861993	F	Antiproliferative activity against mouse CT26 cell line at 10 uM	Mus musculus	13		cell-based format	Scientific Literature
3.	ALA926700	F	Anticancer activity against mouse CT26 cells after 72 hrs by Hoechst test	Mus musculus	3		cell-based format	Scientific Literature
4.	ALA926714	F	Anticancer activity against mouse CT26 cells after 72 hrs in the presence of semicarbazide by Hoechst test	Mus musculus	2		cell-based format	Scientific Literature
5.	ALA926719	F	Anticancer activity against mouse CT26 cells after 72 hrs in the presence of HMTA by Hoechst test	Mus musculus	1		cell-based format	Scientific Literature
6.	ALA926723	F	Anticancer activity against mouse CT26 cells after 72 hrs in the presence of succinate by Hoechst test	Mus musculus	1		cell-based format	Scientific Literature
7.	ALA2015564	F	Cytotoxicity against wild type mouse CT26 cells after 72 hrs by crystal violet staining	Mus musculus	2		cell-based format	Scientific Literature
8.	ALA905858	F	Antitumor activity against mouse CT26 cells	Mus musculus	7		cell-based format	Scientific Literature
9.	ALA905869	F	Reduction of tumor volume in CT26 xenografted in BALB/c mouse at 50 mg/kg, ip relative to control	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA1817198	F	Cytotoxicity against mouse CT26 cells after 3 days by MTT assay	Mus musculus	7		cell-based format	Scientific Literature
11.	ALA981244	F	Antitumor activity against mouse CT26 cells xenografted in BALB/c mouse assessed as time to achieve significant decrease in tumor volume at 5 mg/kg, iv administered on day 3 post tumor challenge for weekly qdx2 schedule	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA981245	F	Antitumor activity against mouse CT26 cells xenografted in BALB/c mouse assessed as time to achieve significant decrease in tumor volume at 20 mg/kg, po administered 3 days post tumor challenge in weekly qdx2 schedule	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA981246	F	Antitumor activity against mouse CT26 cells xenografted in BALB/c mouse assessed as time to achieve significant decrease in tumor volume at 30 mg/kg, po administered 3 days post tumor challenge in weekly qdx2 schedule	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA1117261	F	Growth inhibition of mouse CT26 cells after 72 hrs by MTT assay	Mus musculus	7		cell-based format	Scientific Literature
15.	ALA1218908	F	Induction of apoptosis in mouse CT26 cells assessed as reduction of Bcl-xL protein level at 5 to 10 uM after 24 hrs by immunoblotting	Mus musculus	1		cell-based format	Scientific Literature
16.	ALA1218909	F	Induction of apoptosis in mouse CT26 cells assessed as reduction of Bcl-2 mRNA level at 10 uM after 24 hrs by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
17.	ALA1218910	F	Induction of apoptosis in mouse CT26 cells assessed as reduction of Bcl-xL mRNA level at 10 uM after 24 hrs by RT-PCR analysis	Mus musculus	1		cell-based format	Scientific Literature
18.	ALA1218911	F	Induction of apoptosis in mouse CT26 cells assessed as inhibition of Bcl-2-Bax interaction at 20 uM after 24 hrs by immunoprecipitation analysis	Mus musculus	1		cell-based format	Scientific Literature
19.	ALA1218912	F	Induction of apoptosis in mouse CT26 cells assessed as inhibition of Bcl-xL-Bim interaction at 20 uM after 24 hrs by immunoprecipitation analysis	Mus musculus	1		cell-based format	Scientific Literature
20.	ALA1218913	F	Antitumor activity against mouse CT26 cells xenografted in BALB/c mouse assessed as decrease of tumor volume at 10 umol/kg, po for 12 consecutive days	Mus musculus	1		organism-based format	Scientific Literature